SCHOENECK JAMES A purchased 406.9% of their position (300K shares) of KYNTRA BIO, INC. on the open market
Open‑market purchase worth $105.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/24/2025ACC: 0001415889-25-008823
+300K
Net shares
Net buyer
$105.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
300K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+250K
Price / share
$0.35
Trade value
$88K
% of position
339.1%
3/20/2025
73.72K→323.72K
Common Stock
Indirect
Shares
+50K
Price / share
$0.34
Trade value
$17.04K
% of position
15.4%
3/21/2025
323.72K→373.72K
Total
Net shares
+300K
Net value
$105.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/20/2025 | P · Purchase | +250K | $0.35 | $88K | 339.1% | 73.72K | 323.72K |
| Common Stock Indirect | 3/21/2025 | P · Purchase | +50K | $0.34 | $17.04K | 15.4% | 323.72K | 373.72K |
| Total | +300K | $105.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned28.77K
Total
28.77K direct28.77K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.77K | Direct |
| Total | 28.77K | 28.77K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported